Colon Cancer Clinical Trial

Colorectal Cancer Screening Validation Study

Summary

The purpose of this study is to evaluate the gene expression patterns from colorectal mucosal cells collected through the use of a standard anoscope and cytology brush. Patients will include those scheduled for routine colonoscopy procedures and those with confirmed colorectal cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

willing to provide informed consent
greater than or equal to 50 years of age
patient is scheduled for routine colonoscopy procedure or colorectal cancer surgery
subject is willing to provide colorectal mucosal sample for gene expression testing

Exclusion Criteria:

recent radiation or treatment for gynecologic, prostate or rectal cancer
recent surgery for anal rectal disease
polys, family or self history of cancer (control group only)
GI disease
any mucosal disease or systemic condition that may confound the scientific interpretation of the gene expression results

Study is for people with:

Colon Cancer

Estimated Enrollment:

165

Study ID:

NCT00720993

Recruitment Status:

Unknown status

Sponsor:

IntelliGeneScan, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic
Rochester Minnesota, 55905, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

165

Study ID:

NCT00720993

Recruitment Status:

Unknown status

Sponsor:


IntelliGeneScan, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider